Back to search results

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Abroad (travel likely)Recruiting

Conditions

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer · Pancreatic Cancer · CRC · NSCLC · Pancreas Cancer · Mesothelioma · Ovarian Cancer · Ovarian Neoplasms · Ovarian Carcinoma · Mesothelioma, Malignant · Mesothelioma; Lung · Cancer · Triple Negative Breast Cancer (TNBC) · Renal Cell Carcinoma (Kidney Cancer) · Head and Neck Squamous Cell Carcinoma HNSCC

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Banner Health, Gilbert, Arizona, United States

    Contact: Study coordinator (Jace Luzania) · Jace.Luzania@bannerhealth.com · 480-256-5483
    Contact: Principal Investigator (Matthew Ulrickson, MD)

  • Mayo Clinic Hospital, Phoenix, Arizona, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · 855-776-0015
    Contact: Principal Investigator (Antonious Hazim, MD)

  • City of Hope, Duarte, California, United States

  • University of California San Diego, La Jolla, California, United States

    Contact: Study coordinator (Anthony Oshmago) · aoshmago@health.ucsd.edu
    Contact: Principal Investigator (Sandip Patel, MD)

  • Stanford University, Palo Alto, California, United States

    Contact: Study coordinator (Vivian Leung) · vivian0@stanford.edu
    Contact: Principal Investigator (Wen-Kai Weng, MD)

  • UCLA Medical Center, Santa Monica, California, United States

    Contact: Study coordinator (Karla Largaespada) · KLargaespada@mednet.ucla.edu
    Contact: Principal Investigator (J. Randolph Hecht, MD)
    Edward Garon, MD (Sub-investigator)

  • Mayo Clinic Jacksonville, Jacksonville, Florida, United States

    Contact: Study coordinator (Rhoda Romain) · Romain.Rhoda@mayo.edu
    Contact: Principal Investigator (Yanyan Lou, MD, PhD)

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Katie Ehm) · Katie.Ehm@moffitt.org
    Contact: Principal Investigator (Kedar Kirtane, MD)
    Frederick Locke, MD (Sub-investigator)

  • Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts, United States

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Ethan Sunsvold) · Sundsvold.Ethan@mayo.edu
    Contact: Principal Investigator (Julian Molina, MD, PhD)
    Yi Lin, MD, PhD (Sub-investigator)

  • Washington University, St Louis, Missouri, United States

    Contact: Study coordinator (Hussain Hassan) · hahassan@wustl.edu
    Contact: Principal Investigator (Patrick Grierson, MD, PhD)

  • NYU Langone Medical Center, New York, New York, United States

    Contact: Study coordinator (Kennedi Rainey) · Kennedi.Rainey@nyulangone.org
    Contact: Principal Investigator (Kristen Spencer, DO)

  • The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Dudbeth Brown) · Dudbeth.Brown@osumc.edu · 614-685-7034
    Contact: Principal Investigator (Jinesh Gheeya, MD, PhD)

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Vanderbilt-Ingram Cancer Center Clinical Trials Office (CTO) · CTIP@VUMC.ORG · 1-800-811-8480
    Contact: Principal Investigator (Cathy Eng, M.D., FACP, FASCO)

  • MD Anderson Cancer Center, Houston, Texas, United States

  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Contact: Study coordinator (Shelby Colden)
    Study coordinator · scolden2@fredhutch.org
    Contact: Principal Investigator (Jennifer Specht, MD)
Study leads

  • Eric W Ng, MD, FAAP

    Study Director

    A2 Biotherapeutics Inc.

View source on ClinicalTrials.gov(opens in a new tab)